Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST000763)

(Analysis AN001201)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15	F16	F17	F18	F19	F20
3-METHOXYTYROSINE (M-H)-	ME211543	3.79	NA	0.37	NA	0.32	NA	0.36	0.49	0.34	NA	4.84	NA	0.37	NA	0.50	NA	0.33	0.37	0.38	NA
2-METHYLMALEIC ACID (M-H)-	ME211539	0.70	1.04	1.00	1.62	1.38	0.31	0.57	0.07	1.18	1.06	0.95	0.69	1.02	2.10	0.94	0.40	0.54	NA	0.65	1.20
ACETAMINOPHEN (TN TYLENOL) (M-H)-	ME211551	1.96	0.25	0.67	0.36	1.53	1.40	1.37	NA	0.16	NA	1.43	0.22	0.17	NA	1.56	1.16	0.14	NA	0.15	NA
4-NITROPHENOL (M-H)-	ME211546	0.99	0.99	0.96	0.85	0.95	1.29	1.12	1.24	1.03	1.11	1.07	1.09	0.99	0.81	0.96	1.21	1.00	0.70	1.10	0.80
BENZOIC ACID (M-H)-	ME211559	0.94	0.90	1.16	0.89	1.10	0.89	1.24	0.68	0.99	1.15	0.88	0.91	1.02	0.75	0.94	0.74	0.93	0.76	0.87	0.94
5-HYDROXYTRYPTOPHAN (M-H)-	ME211549	1.05	0.79	0.92	0.69	1.19	0.64	1.27	NA	1.19	1.00	1.14	0.72	0.74	0.61	1.03	0.72	1.37	NA	1.01	1.27
5-HYDROXY OMEPRAZOLE (M-H)-	ME211548	0.49	0.90	1.02	0.00	0.94	1.10	1.72	0.95	1.50	0.37	0.63	1.26	0.75	1.12	1.25	1.15	1.54	0.94	1.23	0.28
CHOLIC ACID (M+CL)-	ME211562	1.58	0.20	0.60	0.23	3.47	0.14	1.71	4.21	0.24	0.04	0.88	1.71	0.61	0.34	1.28	0.19	NA	3.82	0.13	0.04
ARACHIDIC ACID (M-H)-	ME211555	1.68	2.48	0.74	0.61	0.92	0.85	1.35	1.32	1.35	0.96	0.79	1.76	0.69	0.78	0.63	0.62	0.90	1.48	1.25	1.74
ALPHA-HYDROXYISOBUTYRIC ACID (M-H)-	ME211554	1.19	1.99	0.70	0.74	0.96	0.83	0.93	0.68	1.11	1.23	1.22	1.28	0.77	0.85	0.97	0.69	1.18	0.73	1.24	2.35
4-HYDROXYPHENYLACETIC ACID (M-H)-	ME211545	1.56	0.39	0.77	0.55	0.87	0.16	1.56	NA	1.79	0.61	1.19	0.54	0.93	0.45	1.13	NA	1.54	NA	1.15	0.85
CITRULLINE (M-H)-	ME211567	1.06	NA	1.06	0.95	1.06	NA	1.14	NA	1.09	1.03	0.87	NA	1.23	0.58	0.78	NA	0.73	NA	0.82	0.76
5-OXOPROLINE (M-H)-	ME211550	1.11	1.02	1.03	1.02	1.07	0.96	1.32	NA	1.30	0.90	1.02	0.80	0.79	0.79	1.09	0.93	0.88	NA	0.91	0.87
2-HYDROXY-3-METHYLBUTYRIC ACID (M-H)-	ME211538	0.59	5.00	0.93	2.33	0.88	1.22	0.75	1.03	0.97	1.62	0.64	0.50	0.84	0.81	0.89	1.28	0.61	0.95	0.98	5.95
BEHENIC ACID (M-H)-	ME211558	0.94	1.45	0.70	0.52	1.07	2.43	1.37	0.86	0.93	2.27	0.68	1.80	0.78	0.83	0.94	1.46	1.54	0.85	1.00	3.16
3-(4-HYDROXYPHENYL)LACTIC ACID (2M-H)-	ME211540	1.08	0.85	1.03	1.16	1.10	1.06	0.80	NA	1.18	1.31	0.86	1.10	0.87	1.51	0.75	1.34	1.09	NA	1.04	0.79
CHOLIC ACID (2M-H)-	ME211561	2.55	NA	0.48	0.02	1.54	NA	0.57	3.31	NA	NA	0.57	1.33	0.43	0.07	NA	0.02	NA	2.74	NA	NA
ADIPIC ACID (M-H)-	ME211553	1.09	0.95	0.85	0.82	0.86	0.49	1.28	1.21	1.17	0.78	1.13	1.27	0.84	0.99	1.01	0.67	1.20	1.06	1.30	0.71
ARACHIDONIC ACID (M-H)-	ME211556	1.47	2.83	0.72	0.60	0.89	0.60	1.82	1.30	1.48	0.99	0.94	1.80	0.64	0.81	0.68	0.55	0.82	1.39	1.29	0.85
CIS-11-EICOSENOIC ACID (M-H)-	ME211564	1.70	2.68	0.57	0.81	0.89	0.61	1.39	2.11	1.65	1.23	0.98	1.52	0.48	0.80	0.67	0.43	0.81	1.36	1.55	1.18
2-DEOXY-D-GLUCOSE (M+CL)-	ME211537	1.11	1.55	1.23	1.16	0.88	0.91	0.92	0.57	1.46	1.04	1.11	1.38	0.74	0.65	0.77	0.64	0.83	0.74	0.91	0.80
CITRIC ACID (M-H)-	ME211566	0.96	0.97	1.05	1.04	1.00	0.74	0.91	0.88	0.97	1.23	0.96	0.90	1.03	1.00	1.04	0.84	0.99	0.80	1.02	1.01
BILIVERDIN (M-H)-	ME211560	0.96	1.09	1.03	1.60	1.01	0.50	0.91	0.55	1.09	NA	0.97	1.08	1.02	1.70	1.09	0.49	0.86	0.74	1.01	NA
1-METHYLADENOSINE (M+CL)-	ME211531	1.08	0.80	0.97	0.87	0.96	1.24	1.27	1.32	1.21	1.21	1.04	0.70	0.83	0.76	1.05	1.41	1.06	0.96	0.91	0.96
CITRAMALIC ACID (M-H)-	ME211565	0.76	0.58	0.99	1.00	1.00	0.95	0.65	0.31	0.78	1.90	0.88	0.78	1.30	0.86	1.10	0.83	0.97	1.56	1.17	0.93
4-PYRIDOXIC ACID (M-H)-	ME211547	0.53	0.80	1.23	0.76	1.62	0.99	1.04	0.39	0.51	0.65	0.67	1.03	1.09	1.14	1.51	1.06	0.84	0.39	0.61	0.80
ADENOSINE 5^-MONOPHOSPHATE (M-H)-	ME211552	0.76	0.91	0.81	0.90	1.01	1.08	0.66	NA	0.97	NA	1.04	1.10	0.95	0.83	1.32	1.40	0.63	0.47	1.48	NA
18:0 LYSO-PE (M-H)-	ME211536	1.69	1.72	0.81	0.44	0.81	0.46	2.02	1.02	1.18	1.03	0.96	1.09	0.79	0.58	0.72	0.44	0.82	1.33	1.18	0.87
16:0-18:0 PC (M+CL)-	ME211535	0.93	0.79	0.95	1.26	0.94	1.24	1.01	0.52	1.20	1.21	1.07	0.92	0.90	0.80	1.02	1.30	1.08	1.47	1.04	0.98
1-METHYLURIC ACID (2M-H)-	ME211532	0.78	0.33	1.17	1.62	1.30	0.10	1.83	NA	1.38	0.61	0.75	NA	0.44	1.96	1.02	0.10	0.12	NA	2.02	0.68
1-METHYLXANTHINE (M-H)-	ME211534	0.78	0.35	1.13	0.50	1.17	0.81	0.68	NA	0.90	1.56	0.87	0.05	1.14	1.09	1.23	0.89	0.45	0.01	1.39	0.70
1-METHYLURIC ACID (M-H)-	ME211533	0.96	NA	0.65	0.50	1.31	1.00	0.58	NA	1.09	1.43	0.95	NA	0.85	NA	1.37	1.09	0.69	NA	1.67	1.63
CHOLIC ACID (M-H)-	ME211563	2.32	0.40	0.73	0.34	1.93	0.28	0.91	9.98	0.25	0.11	1.41	3.62	0.67	0.57	0.55	0.32	0.10	9.33	0.16	0.17
3-HYDROXY-3-METHYLGLUTARIC ACID (M-H)-	ME211542	1.05	0.92	0.57	0.72	0.80	0.64	0.83	1.18	1.58	NA	0.90	1.37	0.94	0.73	1.02	1.06	0.98	0.68	1.47	NA
AZELAIC ACID (M-H)-	ME211557	0.96	1.13	1.05	1.23	1.06	1.09	1.04	0.96	0.91	0.96	0.90	1.07	0.99	1.11	1.03	1.08	1.03	0.91	0.93	0.83
3-(4-HYDROXYPHENYL)LACTIC ACID (M-H)-	ME211541	0.92	0.96	0.91	0.49	1.25	0.88	0.95	1.63	1.08	1.10	0.78	0.48	1.05	1.49	0.96	1.13	0.83	1.94	1.09	1.58
4-ACETAMINOPHEN SULFATE (M-H)-	ME211544	0.33	0.08	0.26	1.94	0.25	0.27	6.32	NA	0.11	NA	1.47	0.20	0.11	0.00	2.66	0.26	0.04	NA	0.27	NA

Factors:

F1	Exercise:No \| Group:Borderline Pressures \| Sex:Female \| Type:Cath
F2	Exercise:No \| Group:Borderline Pressures \| Sex:Male \| Type:Cath
F3	Exercise:No \| Group:Healthy \| Sex:Female \| Type:Non-invasive
F4	Exercise:No \| Group:Healthy \| Sex:Male \| Type:Non-invasive
F5	Exercise:No \| Group:LowRisk \| Sex:Female \| Type:Non-invasive
F6	Exercise:No \| Group:LowRisk \| Sex:Male \| Type:Non-invasive
F7	Exercise:No \| Group:Normal Pressures \| Sex:Female \| Type:Cath
F8	Exercise:No \| Group:Normal Pressures \| Sex:Male \| Type:Cath
F9	Exercise:No \| Group:PAH \| Sex:Female \| Type:Cath
F10	Exercise:No \| Group:PAH \| Sex:Male \| Type:Cath
F11	Exercise:Yes \| Group:Borderline Pressures \| Sex:Female \| Type:Cath
F12	Exercise:Yes \| Group:Borderline Pressures \| Sex:Male \| Type:Cath
F13	Exercise:Yes \| Group:Healthy \| Sex:Female \| Type:Non-invasive
F14	Exercise:Yes \| Group:Healthy \| Sex:Male \| Type:Non-invasive
F15	Exercise:Yes \| Group:LowRisk \| Sex:Female \| Type:Non-invasive
F16	Exercise:Yes \| Group:LowRisk \| Sex:Male \| Type:Non-invasive
F17	Exercise:Yes \| Group:Normal Pressures \| Sex:Female \| Type:Cath
F18	Exercise:Yes \| Group:Normal Pressures \| Sex:Male \| Type:Cath
F19	Exercise:Yes \| Group:PAH \| Sex:Female \| Type:Cath
F20	Exercise:Yes \| Group:PAH \| Sex:Male \| Type:Cath

Data matrix